Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 2687 clinical trials
featured
Non-Alcoholic Fatty Liver Disease

The Effect of Vitamin E and Docosahexaenoic Acid Ethyl Ester on Non-alcoholic Fatty Liver Disease (NAFLD) - A radomized, doubleblind, placebo-controlled

  • 14 views
  • 25 Jan, 2021
  • 1 location
featured
TREATMENT OF LIVER FIBROSIS IN ADULTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH)

NASH IS LIVER INFLAMMATION AND DAMAGE CAUSED BY A BUILDUP OF FAT IN THE LIVER.  

  • 93 views
  • 03 Oct, 2019
  • 1 location
featured
AHEP0731: Combination Chemotherapy in Treating Young Patients with Newly Diagnosed Liver Cancer

AHEP0731: Combination Chemotherapy in Treating Young Patients with Newly Diagnosed Liver Cancer

  • 400 views
  • 07 Nov, 2020
  • 1 location
featured
Early-stage Hepatocellular Carcinoma

People with liver cirrhosis and recently diagnosed (not yet treated) early-stage hepatocellular carcinoma are asked to participate in a research study being conducted by Montefiore Medical Center

  • 54 views
  • 23 Nov, 2020
  • 1 location
featured
NASH (Nonalcoholic Steatohepatitis)

Nonalcoholic steatohepatitis (NASH) is liver inflammation caused by a buildup of fat in the liver.  ClinSearch is enrolling volunteers with a condition called liver fibrosis from NASH

  • 35 views
  • 23 Nov, 2020
  • 1 location
featured
The AURORA Study

Assessing the efficacy and safety of Cenicriviroc for the treatment of liver fibrosis in adults with non-alcoholic steatohepatitis (NASH)  

  • 295 views
  • 23 Nov, 2020
  • 1 location
featured
BLOOD SAMPLE COLLECTION- UNTREATED MELANOMA

MELANOMA, ALSO KNOWN AS MALIGNANT MELANOMA, IS A TYPE OF CANCER THAT DEVELOPS FROM THE PIGMENT-CONTAINING CELLS KNOWN AS MELANOCYTESUP OF FAT IN THE LIVER.  

  • 13 views
  • 03 Oct, 2019
  • 1 location
featured
NASH

FATTY LIVER OR NASH? Learn more about a clinical research study for individuals with NASH.Insurance is not needed to participate in this study.

  • 0 views
  • 04 Mar, 2021
  • 1 location
featured
A Pilot Phase II Study Using Ibrutinib and Short-Course Fludarabine in Previously Untreated Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

SLL Age greater than or equal to 18 years Not pregnant or breast-feeding women Adequate kidney and liver function Study Design:

monoclonal antibodies
lymphoma
fludarabine
thrombocytopenia
ibrutinib
  • 69 views
  • 15 Apr, 2019
  • 1 location
featured
NASH001 - Non-alcoholic Steatohepatitis (NASH) - CC-90001-NASH-001 - US  

This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter, multinational, dose-finding study evaluating the efficacy of three treatment doses of CC-90001 (100 mg, 200 mg and 400 mg PO QD), compared with placebo, in NASH subjects with Stage 3 and Stage 4 fibrosis.This study is designed to assess response to …

  • 85 views
  • 02 Mar, 2021
  • 39 locations